Jump to content

Draft:Alex Zhavoronkov: Difference between revisions

From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
BOT--Reverting reference addition(s) by 89.106.170.58 to revision 812535331 (https://www.frontiersin.org/journals/genetics/sections/genetics-of-aging#editorial-board [\bfrontiersin\.org\b])
No edit summary
Line 12: Line 12:
|image_size =
|image_size =
|caption =
|caption =
|birth_date =
|birth_date = August 17, 1979 (age 38)
|birth_place =
|birth_place =
|death_date =
|death_date =
|death_place =
|death_place =
|residence =
|residence =
|field = [[aging]], [[regenerative medicine]], aging economics
|field = [[aging]], [[regenerative medicine]], [[drug development]], [[artificial inteligence]]
|work_institutions = Biogerontology Research Foundation
|work_institutions = [[Insilico Medicine]], Biogerontology Research Foundation
|alma_mater = [[Johns Hopkins University]] (JHU)
|alma_mater = [[Johns Hopkins University]] (JHU)
|doctoral_advisor =
|doctoral_advisor =
Line 47: Line 47:
| first2 =
| first2 =
| doi = 10.1038/nbt0717-604
| doi = 10.1038/nbt0717-604
}}</ref> director of the Biogerontology Research Foundation,<ref name="CharitiesCommission">[http://apps.charitycommission.gov.uk/Accounts/Ends54/0001124054_AC_20130228_E_C.pdf Charities Commission UK 2013 Trustee Report and Statement of Accounts]</ref>{{Primary source inline|date=November 2017}} a UK-based think-tank for aging research, and is also the director of the [[International Aging Research Portfolio]], an open-access repository of biomedical grants.<ref>{{Cite journal
}}</ref> the director of the Biogerontology Research Foundation,<ref name=Biogerontology Research Foundation Salutes Staff On Multi-Year Drug Development Agreement>{{cite web|title=Biogerontology Research Foundation Salutes Staff On Multi-Year Drug Development Agreement|url=https://bioengineer.org/biogerontology-research-foundation-salutes-staff-on-multi-year-drug-development-agreement/|website=Bioengineer.org|accessdate=28 November 2017}}</ref> a UK-based think-tank for aging research, and also the director of the [[International Aging Research Portfolio]], an open-access repository of biomedical grants. He is the adjunct professor at the [[Moscow Institute of Physics and Technology]]<ref name="MIPT">[https://mipt.ru/english/news/neural_network_learns_to_select_potential_anticancer_drugs MIPT] MIPT News: Neural network learns to select potential anticancer drugs 02.09.2017</ref>.
| pmid = 21799912
| pmc = 3142169
| year = 2011
| author1 = Zhavoronkov
| first1 = A
| title = Methods for structuring scientific knowledge from many areas related to aging research
| journal = PLoS ONE
| volume = 6
| issue = 7
| pages = e22597
| last2 = Cantor
| first2 = C. R.
| doi = 10.1371/journal.pone.0022597
}}</ref>{{Primary source inline|date=November 2017}}<ref>{{Cite journal
| pmid = 24587817
| pmc = 3920912
| year = 2014
| author1 = Kolesov
| first1 = A
| title = On multilabel classification methods of incompletely labeled biomedical text data
| journal = Computational and Mathematical Methods in Medicine
| volume = 2014
| pages = 781807
| last2 = Kamyshenkov
| first2 = D
| last3 = Litovchenko
| first3 = M
| last4 = Smekalova
| first4 = E
| last5 = Golovizin
| first5 = A
| last6 = Zhavoronkov
| first6 = A
| doi = 10.1155/2014/781807
}}</ref>{{Primary source inline|date=November 2017}}<ref>[http://www.longevitymedicine.tv/longevity-medicine/the-international-aging-research-portfolio-launches.php The International Aging Research Portfolio Launches] Longevity Medicine, retrieved 27 Feb 2011.</ref>{{Primary source inline|date=November 2017}} He is the adjunct professor at the [[Moscow Institute of Physics and Technology]]<ref name="MIPT">[https://mipt.ru/english/news/neural_network_learns_to_select_potential_anticancer_drugs MIPT] MIPT News: Neural network learns to select potential anticancer drugs 02.09.2017</ref>.


==Education==
==Education==
Zhavoronkov earned two bachelor's degrees at [[Queen's University]] in computer science and commerce. He has a master's in biotechnology from [[Johns Hopkins University]] and a PhD in physics and mathematics from [[Moscow State University]].<ref>[http://lifeboat.com/ex/bios.alexander.zhavoronkov Biography of Alexander Zhavoronkov] Lifeboat.com</ref>
Zhavoronkov earned two bachelor's degrees at [[Queen's University]] in computer science and commerce. He has a master's in biotechnology from [[Johns Hopkins University]] and a PhD in physics and mathematics from [[Moscow State University]].<ref>[https://www.bloomberg.com/research/stocks/private/person.asp?personId=262251019&privcapId=262146361&previousCapId=262146361&previousTitle=Insilico%20Medicine,%20Inc. Executive Profile of Alexander Zhavoronkov] Bloomberg.com</ref>


==Career==
==Career==
He is the co-founder and CEO of [[Insilico Medicine]], a company dedicated to drug discovery for cancer and aging located at the Emerging Technology Centers of the [[Johns Hopkins University]].<ref>[https://www.genomeweb.com/informatics/silico-medicine-opens-us-office-prepares-launch-drug-discovery-software-aging-re GenomeWeb: In Silico Medicine Opens US Office, Prepares to Launch Drug Discovery Software for Aging Research Market by Uduak Grace Thomas, March 28, 2014]</ref> <ref>[http://www.baltimoresun.com/business/bs-bz-insilico-medicine-raise-20170223-story.html Baltimore Sun, Insilico Medicine raises $10 million, by Sarah Gantz, February 23, 2017]</ref>
He is the co-founder and CEO of [[Insilico Medicine]], a [[deep learning]] company focused on [[drug discovery]] and [[biomarker]] development for aging and [[aging-associated diseases]] located at the Emerging Technology Centers of the [[Johns Hopkins University]].<ref>[https://www.genomeweb.com/informatics/silico-medicine-opens-us-office-prepares-launch-drug-discovery-software-aging-re GenomeWeb: In Silico Medicine Opens US Office, Prepares to Launch Drug Discovery Software for Aging Research Market by Uduak Grace Thomas, March 28, 2014]</ref> <ref>[http://www.baltimoresun.com/business/bs-bz-insilico-medicine-raise-20170223-story.html Baltimore Sun, Insilico Medicine raises $10 million, by Sarah Gantz, February 23, 2017]</ref>


==Publications==
==Publications==
Since 2011, Dr. Zhavoronkov authored and co-authored over 100 scientific articles<ref>[https://scholar.google.com/citations?hl=en&user=8Icccp0AAAAJ&view_op=list_works&sortby=pubdate Google Scholar by Publication Date] Google Scholar by Publication Date</ref> with over 85 papers referenced in [[PubMed]].<ref name="Pubmed">[https://www.ncbi.nlm.nih.gov/pubmed/?term=zhavoronkov%2Ba PubMed Bibliography] Pubmed</ref> Many of the highest-impact research papers focus on the applications of [[deep learning]] techniques to drug discovery, biomarker development and aging research.<ref>[https://scholar.google.com/citations?hl=en&user=8Icccp0AAAAJ&view_op=list_works Google Scholar by Citation] Google Scholar by Citation</ref> He has contributed articles on trends in aging and longevity for the popular press including [[Huffington Post]],<ref>[http://www.huffingtonpost.com/alex-zhavoronkov/13-reasons-why-we-will-li_b_3519357.html Huffington Post: 13 Reasons Why We Will Live Longer Than Our Parents]</ref> [[Financial Times]] Pensions Expert,<ref>[http://www.pensions-expert.com/Comment-Analysis/A-scheme-guide-to-changing-longevity-risk [Financial Times Pensions Expert: A scheme guide to changing longevity risk]</ref> [[Next Avenue]],<ref>[https://www.forbes.com/sites/nextavenue/2013/10/02/why-we-should-look-forward-to-living-to-120-and-beyond/ Next Avenue, Why We Should Look Forward To Living To 120 And Beyond]</ref> and [[New Scientist]].<ref>[https://www.newscientist.com/article/dn28531-label-ageing-as-a-disease-and-unleash-the-hunt-for-a-cure/ New Scientist]</ref>
Since 2011, Dr. Zhavoronkov authored and co-authored over 100 scientific articles<ref>[https://scholar.google.com/citations?hl=en&user=8Icccp0AAAAJ&view_op=list_works&sortby=pubdate Google Scholar by Publication Date] Google Scholar by Publication Date</ref> with over 85 papers referenced in [[PubMed]].<ref name="Pubmed">[https://www.ncbi.nlm.nih.gov/pubmed/?term=zhavoronkov%2Ba PubMed Bibliography] Pubmed</ref> Many of the highest-impact research papers focus on the applications of deep learning techniques to drug discovery, biomarker development and aging research.<ref>[https://scholar.google.com/citations?hl=en&user=8Icccp0AAAAJ&view_op=list_works Google Scholar by Citation] Google Scholar by Citation</ref> He has contributed articles on trends in aging and longevity for the popular press including [[Huffington Post]],<ref>[http://www.huffingtonpost.com/alex-zhavoronkov/13-reasons-why-we-will-li_b_3519357.html Huffington Post: 13 Reasons Why We Will Live Longer Than Our Parents]</ref> [[Financial Times]] Pensions Expert,<ref>[http://www.pensions-expert.com/Comment-Analysis/A-scheme-guide-to-changing-longevity-risk [Financial Times Pensions Expert: A scheme guide to changing longevity risk]</ref> [[Next Avenue]],<ref>[https://www.forbes.com/sites/nextavenue/2013/10/02/why-we-should-look-forward-to-living-to-120-and-beyond/ Next Avenue, Why We Should Look Forward To Living To 120 And Beyond]</ref> and [[New Scientist]].<ref>[https://www.newscientist.com/article/dn28531-label-ageing-as-a-disease-and-unleash-the-hunt-for-a-cure/ New Scientist]</ref>


In November 2017 together with the collaborators from the [http://www.BitFury.com BitFury Group] he proposed the application of the deep learning techniques and [[blockchain]] technology for managing human life data<ref>[https://sk.ru/news/b/news/archive/2017/11/21/skolkovo-scientist-says-ai-and-blockchain-could-accelerate-biomedical-research.aspx Skolkovo Commentary: Skolkovo scientist says AI and blockchain could accelerate biomedical research]</ref> and presented the concept at the [[Singularity University]] Exponential Medicine conference in San Diego<ref>[https://www.youtube.com/watch?v=NAAXot65-9g&feature=youtu.be&t=9h26m43s Alex Zhavoronkov presentation at the Exponential Medicine]</ref>,<ref>[https://singularityhub.com/2017/11/19/drug-discovery-ai-to-scour-a-universe-of-molecules-for-wonder-drugs/ Singularity University Hub: AI to Scour a Universe of Molecules for Wonder Drugs]</ref>.
He holds a US patent for methods utilizing brain-computer interfaces for recognizing imagined visual images.<ref>{{Cite journal

==Editorial Roles and Conferences==
Dr. Zhavoronkov is the editor of [http://www.aging-us.com/ Aging] <ref>[http://www.aging-us.com/editorial-board Aging Editorial Board]</ref> and associate editor of Frontiers in Genetics of Aging<ref>[https://www.frontiersin.org/journals/genetics/sections/genetics-of-aging#editorial-board Frontiers in Genetics of Aging Editorial Board]</ref>. He co-founded the "Annual Aging Research for Drug Discovery Forum" in Basel, Switzerland in 2014, previously called the International Symposium on Geroprotectors <ref>[https://www.newscientist.com/article/mg22429894-000-everyday-drugs-could-give-extra-years-of-life/ New Scientist report from the International Symposium on Geroprotectors in Basel]</ref> as part of the EMBO/Basel Life<ref>[https://www.basellife.org/aging-and-drug-discovery 4th Annual Aging Research & Drug Discovery Forum in Basel, Switzerland]</ref>.

⚫
==Books==
⚫
*{{cite book|first=Alex |last=Zhavoronkov|title=The Ageless Generation: How Advances in Biomedicine Will Transform the Global Economy|publisher=Macmillan|year=2013|ISBN =978-0230342200}}
⚫
::*Featured in mainstream and business media<ref name="Edge">{{cite news|url=http://www.edgeonthenet.com/entertainment/books/non-fiction/146143/the_ageless_generation:_how_advances_in_biomedicine_will_transform_the_global_economy |title=The Ageless Generation: How Advances in Biomedicine Will Transform the Global Economy (review) |first=Daniel |last=Scheffler |date=July 9, 2013}}</ref> including coverage in the Critic section of [[Bloomberg Businessweek]],<ref>Bloomberg Business week, Critic 07.22.2013 pp. 74</ref> on CBS and online radio stations,<ref name="CBSradio">[http://audio.cbsradionewsfeed.com/2013/08/09/15/W0040809_1801_2523613.mp3 CBS Radio with Dan Raviv in Washington, DC]</ref><ref name ="BookTour">[http://booktourradio.com/ageless/ Book Tour Radio]</ref> and translated into both Japanese<ref>[http://kw.maruzen.co.jp/ims/itemDetail.html?te-uniquekey=1520aa39098 Ageless Generation on Maruzen]</ref> and Polish<ref>[http://archiwum.allegro.pl/oferta/pokolenie-wiecznej-mlodosci-alex-zhavoronkov-i5631600956.html Ageless Generation in Polish]</ref> by independent publishers.
⚫
*{{citation|first=Alex |last=Zhavoronkov|title=Dating A.I.: A guide to falling in love with Artificial Intelligence|publisher=[[RE/Search]]|year=2012|ISBN=978-1889307350}}

==Patents==
*{{US patent reference
| number = 8442626B2
| issue-date = May 14, 2013
| inventor = Alex Zavoronkov, Mikhail Bakhnyan
| title = Systems and methods for communicating with a computer using brain activity patterns
}}<ref>{{Cite journal
| pmid = 21695206
| pmid = 21695206
| pmc = 3112189
| pmc = 3112189
Line 115: Line 96:
| first6 = A
| first6 = A
| doi = 10.1371/journal.pone.0020674
| doi = 10.1371/journal.pone.0020674
}}</ref>
}}</ref>{{Primary source inline|date=November 2017}}<ref name="BCI">[https://patents.google.com/patent/US8442626B2 Patent on BCI for recognizing imagined visual images]</ref>{{Primary source inline|date=November 2017}}

⚫
==Books==
⚫
*{{cite book|first=Alex |last=Zhavoronkov|title=The Ageless Generation: How Advances in Biomedicine Will Transform the Global Economy|publisher=Macmillan|year=2013|ISBN =978-0230342200}}
⚫
::Featured in mainstream and business media<ref name="Edge">{{cite news|url=http://www.edgeonthenet.com/entertainment/books/non-fiction/146143/the_ageless_generation:_how_advances_in_biomedicine_will_transform_the_global_economy |title=The Ageless Generation: How Advances in Biomedicine Will Transform the Global Economy (review) |first=Daniel |last=Scheffler |date=July 9, 2013}}</ref> including coverage in the Critic section of [[Bloomberg Businessweek]],<ref>Bloomberg Business week, Critic 07.22.2013 pp. 74</ref> on CBS and online radio stations,<ref name="CBSradio">[http://audio.cbsradionewsfeed.com/2013/08/09/15/W0040809_1801_2523613.mp3 CBS Radio with Dan Raviv in Washington, DC]</ref><ref name ="BookTour">[http://booktourradio.com/ageless/ Book Tour Radio]</ref><ref>[http://skepticallyspeaking.ca/episodes/216-the-evolution-of-aging-2 The Evolution of Aging] Skeptically Speaking, retrieved June 7, 2013</ref> and translated into both Japanese<ref>[http://kw.maruzen.co.jp/ims/itemDetail.html?te-uniquekey=1520aa39098 Ageless Generation on Maruzen]</ref> and Polish<ref>[http://archiwum.allegro.pl/oferta/pokolenie-wiecznej-mlodosci-alex-zhavoronkov-i5631600956.html Ageless Generation in Polish]</ref> by independent publishers.
⚫
*{{citation|first=Alex |last=Zhavoronkov|title=Dating A.I.: A guide to falling in love with Artificial Intelligence|publisher=[[RE/Search]]|year=2012|ISBN=978-1889307350}}


==References==
==References==
Line 127: Line 103:
==External links==
==External links==
*[http://loop.frontiersin.org/people/70940/bio Editor biography at Frontiers]
*[http://loop.frontiersin.org/people/70940/bio Editor biography at Frontiers]
*[https://www.researchgate.net/profile/Alexander_Zhavoronkov Research gate profile]
*[https://www.researchgate.net/profile/Alexander_Zhavoronkov ResearchGate profile]
*[http://orcid.org/0000-0001-7067-8966 ORCID ID]
*[http://orcid.org/0000-0001-7067-8966 ORCID ID]
*[https://www.amazon.com/Alex-Zhavoronkov/e/B00C7CN4WU/ Author profile at Amazon]
*[https://www.amazon.com/Alex-Zhavoronkov/e/B00C7CN4WU/ Author profile at Amazon]
*[http://bg-rf.org.uk/ The Biogerotology Research Foundation]
*[http://bg-rf.org.uk/ The Biogerontology Research Foundation]


{{Authority control}}
{{Authority control}}

Revision as of 14:04, 29 November 2017

This template is being used in the wrong namespace. To nominate this talk page for deletion, go to Miscellany for deletion.

Alex Zhavoronkov
BornAugust 17, 1979 (age 38)
Alma materJohns Hopkins University (JHU)
Scientific career
Fieldsaging, regenerative medicine, drug development, artificial inteligence
InstitutionsInsilico Medicine, Biogerontology Research Foundation

Alex Zhavoronkov is a scientist working in biotechnology, regenerative medicine, and aging economics. He is the founder of Insilico Medicine,[1] the director of the Biogerontology Research Foundation,Cite error: The <ref> tag has too many names (see the help page). a UK-based think-tank for aging research, and also the director of the International Aging Research Portfolio, an open-access repository of biomedical grants. He is the adjunct professor at the Moscow Institute of Physics and Technology[2].

Education

Zhavoronkov earned two bachelor's degrees at Queen's University in computer science and commerce. He has a master's in biotechnology from Johns Hopkins University and a PhD in physics and mathematics from Moscow State University.[3]

Career

He is the co-founder and CEO of Insilico Medicine, a deep learning company focused on drug discovery and biomarker development for aging and aging-associated diseases located at the Emerging Technology Centers of the Johns Hopkins University.[4] [5]

Publications

Since 2011, Dr. Zhavoronkov authored and co-authored over 100 scientific articles[6] with over 85 papers referenced in PubMed.[7] Many of the highest-impact research papers focus on the applications of deep learning techniques to drug discovery, biomarker development and aging research.[8] He has contributed articles on trends in aging and longevity for the popular press including Huffington Post,[9] Financial Times Pensions Expert,[10] Next Avenue,[11] and New Scientist.[12]

In November 2017 together with the collaborators from the BitFury Group he proposed the application of the deep learning techniques and blockchain technology for managing human life data[13] and presented the concept at the Singularity University Exponential Medicine conference in San Diego[14],[15].

Editorial Roles and Conferences

Dr. Zhavoronkov is the editor of Aging [16] and associate editor of Frontiers in Genetics of Aging[17]. He co-founded the "Annual Aging Research for Drug Discovery Forum" in Basel, Switzerland in 2014, previously called the International Symposium on Geroprotectors [18] as part of the EMBO/Basel Life[19].

Books

  • Zhavoronkov, Alex (2013). The Ageless Generation: How Advances in Biomedicine Will Transform the Global Economy. Macmillan. ISBN 978-0230342200.
  • Featured in mainstream and business media[20] including coverage in the Critic section of Bloomberg Businessweek,[21] on CBS and online radio stations,[22][23] and translated into both Japanese[24] and Polish[25] by independent publishers.

Patents

  • US patent 8442626B2, Alex Zavoronkov, Mikhail Bakhnyan, "Systems and methods for communicating with a computer using brain activity patterns", issued May 14, 2013 [26]

References

  1. ^ Eric Smaley (2017). "AI-powered drug discovery captures pharma interest". Nature Biotechnology. 35 (7): 605. doi:10.1038/nbt0717-604. PMID 28700560.
  2. ^ MIPT MIPT News: Neural network learns to select potential anticancer drugs 02.09.2017
  3. ^ Executive Profile of Alexander Zhavoronkov Bloomberg.com
  4. ^ GenomeWeb: In Silico Medicine Opens US Office, Prepares to Launch Drug Discovery Software for Aging Research Market by Uduak Grace Thomas, March 28, 2014
  5. ^ Baltimore Sun, Insilico Medicine raises $10 million, by Sarah Gantz, February 23, 2017
  6. ^ Google Scholar by Publication Date Google Scholar by Publication Date
  7. ^ PubMed Bibliography Pubmed
  8. ^ Google Scholar by Citation Google Scholar by Citation
  9. ^ Huffington Post: 13 Reasons Why We Will Live Longer Than Our Parents
  10. ^ [Financial Times Pensions Expert: A scheme guide to changing longevity risk
  11. ^ Next Avenue, Why We Should Look Forward To Living To 120 And Beyond
  12. ^ New Scientist
  13. ^ Skolkovo Commentary: Skolkovo scientist says AI and blockchain could accelerate biomedical research
  14. ^ Alex Zhavoronkov presentation at the Exponential Medicine
  15. ^ Singularity University Hub: AI to Scour a Universe of Molecules for Wonder Drugs
  16. ^ Aging Editorial Board
  17. ^ Frontiers in Genetics of Aging Editorial Board
  18. ^ New Scientist report from the International Symposium on Geroprotectors in Basel
  19. ^ 4th Annual Aging Research & Drug Discovery Forum in Basel, Switzerland
  20. ^ Scheffler, Daniel (July 9, 2013). "The Ageless Generation: How Advances in Biomedicine Will Transform the Global Economy (review)".
  21. ^ Bloomberg Business week, Critic 07.22.2013 pp. 74
  22. ^ CBS Radio with Dan Raviv in Washington, DC
  23. ^ Book Tour Radio
  24. ^ Ageless Generation on Maruzen
  25. ^ Ageless Generation in Polish
  26. ^ Bobrov, P; Frolov, A; Cantor, C; Fedulova, I; Bakhnyan, M; Zhavoronkov, A (2011). "Brain-computer interface based on generation of visual images". PLoS ONE. 6 (6): e20674. doi:10.1371/journal.pone.0020674. PMC 3112189. PMID 21695206.{{cite journal}}: CS1 maint: unflagged free DOI (link)

External links

Retrieved from "https://en.wikipedia.org/w/index.php?title=Draft:Alex_Zhavoronkov&oldid=812722969"